CVS Health Pre-Paid Expenses 2010-2025 | CVS
CVS Health pre-paid expenses from 2010 to 2025. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
- CVS Health pre-paid expenses for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
- CVS Health pre-paid expenses for 2024 were $0B, a 0% decline from 2023.
- CVS Health pre-paid expenses for 2023 were $0B, a 0% decline from 2022.
- CVS Health pre-paid expenses for 2022 were $0B, a 0% decline from 2021.
| CVS Health Annual Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| CVS Health Quarterly Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $79.000B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.269B | 25.37 |
| Elevance Health (ELV) | United States | $85.392B | 11.02 |
| Cencora (COR) | United States | $56.052B | 19.50 |
| DiDi Global (DIDIY) | China | $22.921B | 34.79 |
| Natera (NTRA) | United States | $22.013B | 0.00 |
| BioMerieux (BMXMF) | France | $15.348B | 0.00 |
| Solventum (SOLV) | United States | $12.566B | 13.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.094B | 0.00 |
| CochLear (CHEOY) | Australia | $11.426B | 0.00 |
| Revvity (RVTY) | United States | $10.766B | 18.53 |
| ICON (ICLR) | Ireland | $10.566B | 9.82 |
| Viatris (VTRS) | United States | $10.082B | 3.46 |
| Doximity (DOCS) | United States | $9.641B | 44.90 |
| Avantor (AVTR) | United States | $8.879B | 12.90 |
| HealthEquity (HQY) | United States | $8.778B | 43.18 |
| Medpace Holdings (MEDP) | United States | $8.445B | 22.43 |
| Sonic Healthcare (SKHHY) | Australia | $8.256B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.692B | 13.11 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.050B | 23.88 |
| BrightSpring Health Services (BTSG) | United States | $4.042B | 37.42 |
| Sotera Health (SHC) | United States | $3.463B | 19.68 |
| Alignment Healthcare (ALHC) | United States | $2.978B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.933B | 38.14 |
| Concentras Parent (CON) | United States | $2.751B | 15.90 |
| Organon (OGN) | United States | $2.379B | 2.53 |
| Ardent Health Partners (ARDT) | United States | $2.120B | 9.04 |
| GeneDx Holdings (WGS) | United States | $1.998B | 76.94 |
| Premier (PINC) | United States | $1.885B | 14.31 |
| Progyny (PGNY) | United States | $1.822B | 40.09 |
| PACS (PACS) | United States | $1.494B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.179B | 8.97 |
| Establishment Labs Holdings (ESTA) | $1.038B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| CareDx (CDNA) | United States | $0.978B | 15.27 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| Nutex Health (NUTX) | United States | $0.921B | 13.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.810B | 7.58 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.617B | 4.15 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.525B | 43.17 |
| LifeMD (LFMD) | United States | $0.521B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.479B | 10.78 |
| SBC Medicals (SBC) | United States | $0.466B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.395B | 0.00 |
| Oncology Institute (TOI) | United States | $0.278B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.146B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| OncoCyte (OCX) | United States | $0.095B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.050B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.019B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |